US FDA seeks advice on adding physical-chemical identifiers to drugs
This article was originally published in Scrip
Executive Summary
The US FDA is seeking comments on draft guidelines governing the incorporation of physical-chemical identifiers (PCIDs) into solid oral dosage form drugs in an effort to thwart counterfeiting.